# Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction

> **NCT03413891** · PHASE4 · TERMINATED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 222 (actual)

## Conditions studied

- Tooth Extraction

## Interventions

- **DRUG:** Tranexamic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03413891
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-07
- **Primary completion:** 2020-03-19
- **Final completion:** 2020-03-19
- **Target enrollment:** 222 (ACTUAL)
- **Why stopped:** Advice from DSMB
- **Last updated:** 2024-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03413891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03413891, "Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03413891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*